It has been reported that compound 11a (subsequently designated as D156844) elevated the endogenous mouse Smn mRNA in NSC-34 cells, raised SMN protein levels and dramatically increased the numbers of SMN-positive nuclear foci (gems) in SMA patient fibroblasts [11]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.